| Filed | Form | Items | Signal | Score | Summary | Link |
|---|---|---|---|---|---|---|
| 2026-06-12 17:15 | 8-K | ["8.01"] | other | 0.15 | Shareholder meeting adjournment due to lack of quorum; no M&A indicators present. | SEC · detail |
| 2026-06-12 10:26 | 8-K | ["1.01"] | material agreement | 0.15 | Aspire Biopharma entered asset purchase agreement with FireFish TopCo for $30M acquisition of business units, not M&A target. | SEC · detail |